Mitochondrial single nucleotide polymorphism genotyping by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using cleavable biotinylated dideoxynucleotides.

Characterization of mitochondrial DNA (mtDNA) single nucleotide polymorphisms (SNPs) and mutations is crucial for disease diagnosis, which requires accurate and sensitive detection methods and quantification due to mitochondrial heteroplasmy. We report here the characterization of mutations for myoclonic epilepsy with ragged red fibers syndrome using chemically cleavable biotinylated dideoxynucleotides and a mass spectrometry (MS)-based solid phase capture (SPC) single base extension (SBE) assay. The method effectively eliminates unextended primers and primer dimers, and the presence of cleavable linkers between the base and biotin allows efficient desalting and release of the DNA products from solid phase for MS analysis. This approach is capable of high multiplexing, and the use of different length linkers for each of the purines and each of the pyrimidines permits better discrimination of the four bases by MS. Both homoplasmic and heteroplasmic genotypes were accurately determined on different mtDNA samples. The specificity of the method for mtDNA detection was validated by using mitochondrial DNA-negative cells. The sensitivity of the approach permitted detection of less than 5% mtDNA heteroplasmy levels. This indicates that the SPC-SBE approach based on chemically cleavable biotinylated dideoxynucleotides and MS enables rapid, accurate, and sensitive genotyping of mtDNA and has broad applications for genetic analysis.

[1]  S. Dimauro,et al.  A novel mitochondrial tRNA(Leu(UUR)) mutation in a patient with features of MERRF and Kearns-Sayre syndrome. , 2003, Neuromuscular Disorders.

[2]  S. Dimauro,et al.  Therapeutic prospects for mitochondrial disease. , 2010, Trends in molecular medicine.

[3]  Mark Stoneking,et al.  Detecting heteroplasmy from high-throughput sequencing of complete human mitochondrial DNA genomes. , 2010, American journal of human genetics.

[4]  C R Cantor,et al.  Chip-based genotyping by mass spectrometry. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[5]  S. Dimauro,et al.  A novel mitochondrial tRNALeu(UUR) mutation in a patient with features of MERRF and Kearns–Sayre syndrome , 2003, Neuromuscular Disorders.

[6]  J. Ju,et al.  Solid phase capturable dideoxynucleotides for multiplex genotyping using mass spectrometry. , 2002, Nucleic acids research.

[7]  E. Schon,et al.  In vitro analysis of mutations causing myoclonus epilepsy with ragged-red fibers in the mitochondrial tRNA(Lys)gene: two genotypes produce similar phenotypes , 1995, Molecular and cellular biology.

[8]  K. Seong,et al.  Mutational analysis of whole mitochondrial DNA in patients with MELAS and MERRF diseases , 2010, Experimental & Molecular Medicine.

[9]  S. Dimauro,et al.  Maternally inherited cardiomyopathy and hearing loss associated with a novel mutation in the mitochondrial tRNA(Lys) gene (G8363A). , 1996, American journal of human genetics.

[10]  H. Pfeiffer,et al.  Application of mtDNA SNP analysis in forensic casework. , 2011, Forensic science international. Genetics.

[11]  Shamkant B. Navathe,et al.  MITOMAP: a human mitochondrial genome database--1998 update , 1998, Nucleic Acids Res..

[12]  D. Wallace.  Mitochondria as Chi , 2008, Genetics.

[13]  J M Butler,et al.  Single nucleotide polymorphism determination using primer extension and time‐of‐flight mass spectrometry , 1999, Electrophoresis.

[14]  S. Dimauro.  Mitochondrial Encephalomyopathies , 1992, Brain pathology.

[15]  Jean-Pierre Mazat,et al.  Mitochondrial threshold effects. , 2003, The Biochemical journal.

[16]  G. Guazzi,et al.  The A to G transition at nt 3243 of the mitochondrial tRNALeu(UUR) may cause an MERRF syndrome. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[17]  D. Dressman,et al.  Heteroplasmic mitochondrial DNA mutations in normal and tumor cells , 2010, Nature.

[18]  S. Dimauro,et al.  Biochemical analysis of respiratory function in cybrid cell lines harbouring mitochondrial DNA mutations. , 2004, The Biochemical journal.

[19]  A. Harding,et al.  A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. , 1990, American journal of human genetics.

[20]  Á. Carracedo,et al.  Applications of MALDI‐TOF MS to large‐scale human mtDNA population‐based studies , 2009, Electrophoresis.

[21]  Mark R. Wilson,et al.  Forensics and mitochondrial DNA: applications, debates, and foundations. , 2003, Annual review of genomics and human genetics (Print).

[22]  P. Ross,et al.  High level multiplex genotyping by MALDI-TOF mass spectrometry , 1998, Nature Biotechnology.

[23]  Jingyue Ju,et al.  Design and synthesis of cleavable biotinylated dideoxynucleotides for DNA sequencing by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2012, Analytical biochemistry.

[24]  Lee-Jun C Wong,et al.  Detection and quantification of heteroplasmic mutant mitochondrial DNA by real-time amplification refractory mutation system quantitative PCR analysis: a single-step approach. , 2004, Clinical chemistry.

[25]  Bruce P. Neri,et al.  Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes , 1999, Nature Biotechnology.

[26]  D. Wallace,et al.  Mitochondrial DNA variation in human evolution and disease. , 1999, Gene.

[27]  J. Arenas,et al.  Sporadic MERRF/MELAS overlap syndrome associated with the 3243 tRNALeu(UUR) mutation of mitochondrial DNA , 1996, Muscle & nerve.

[28]  S. Dimauro,et al.  A functionally dominant mitochondrial DNA mutation. , 2008, Human molecular genetics.

[29]  D. Sarracino,et al.  Rapid genotyping by MALDI-monitored nuclease selection from probe libraries , 2000, Nature Biotechnology.

[30]  S. Dimauro,et al.  A new mtDNA mutation in the tRNA(Lys) gene associated with myoclonic epilepsy and ragged-red fibers (MERRF). , 1992, American journal of human genetics.

[31]  Jingyue Ju,et al.  Digital genotyping using molecular affinity and mass spectrometry , 2003, Nature Reviews Genetics.

[32]  Jun-yan Hong,et al.  Multiplex genotyping of cytochrome p450 single-nucleotide polymorphisms by use of MALDI-TOF mass spectrometry. , 2007, Clinical chemistry.

[33]  Sha Tang,et al.  Characterization of mitochondrial DNA heteroplasmy using a parallel sequencing system. , 2010, BioTechniques.

[34]  Jingyue Ju,et al.  Thirtyfold multiplex genotyping of the p53 gene using solid phase capturable dideoxynucleotides and mass spectrometry. , 2004, Genomics.

[35]  Lahiri Kanth Nanduri,et al.  Validation of microarray‐based resequencing of 93 worldwide mitochondrial genomes , 2009, Human mutation.

[36]  L. Wong.  Pathogenic mitochondrial DNA mutations in protein‐coding genes , 2007, Muscle & nerve.

[37]  D. Wallace.  Mitochondrial diseases in man and mouse. , 1999, Science.

[38]  R. Naviaux,et al.  Mitochondrial DNA Mutation Detection by Electrospray Mass Spectrometry , 2007, Clinical chemistry.

[39]  W. Holzgreve,et al.  A rapid and accurate approach to identify single nucleotide polymorphisms of mitochondrial DNA using MALDI-TOF mass spectrometry , 2008, Clinical chemistry and laboratory medicine.